R. T. Barrow

发表

The humoral response to human factor VIII in hemophilia A mice

P. Lollar, E. Parker, W. Church, 2007, Journal of thrombosis and haemostasis : JTH.

Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.

P. Lollar, E. Parker, S. Krishnaswamy, 1994, The Journal of biological chemistry.

Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors.

S. Meeks, J. Healey, P. Lollar, 2008, Blood.

Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation.

S. Meeks, J. Healey, P. Lollar, 2007, Blood.

Short title: Anti-factor VIII C2 domain antibody epitopes

S. Meeks, J. Healey, P. Lollar, 2007 .

Factor VIII inhibitors.

J. Healey, P. Lollar, E. Parker, 2001, Advances in experimental medicine and biology.

Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII

P. Lollar, R. T. Barrow, R. T. BARROW, 2006, Journal of thrombosis and haemostasis : JTH.

Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope.

J. Healey, P. Lollar, E. Parker, 2004, Blood.

Identification of Porcine Coagulation Factor VIII Domains Responsible for High Level Expression via Enhanced Secretion*

C. Doering, J. Healey, P. Lollar, 2004, Journal of Biological Chemistry.

High Level Expression of Recombinant Porcine Coagulation Factor VIII*

C. Doering, J. Healey, P. Lollar, 2002, The Journal of Biological Chemistry.

Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.

J. Healey, P. Lollar, D. Scandella, 2000, Blood.

The comparative immunogenicity of human and porcine factor VIII in haemophilia A mice

J. Healey, P. Lollar, E. Parker, 2009, Thrombosis and Haemostasis.

Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.

J. Healey, P. Lollar, M. Shima, 1998, Blood.

Comparative immunogenicity of recombinant B domain‐deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII

P. Lollar, E. Parker, R. T. Barrow, 2004, Journal of thrombosis and haemostasis : JTH.

Expression and Characterization of Recombinant Murine Factor VIII

C. Doering, J. Healey, P. Lollar, 2002, Thrombosis and Haemostasis.

hemophilia A mice by mutagenesis of the A2 domain B-cell epitope Reduction of the inhibitory antibody response to human factor VIII in

J. Healey, P. Lollar, E. Parker, 2010 .

A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function.

Shannon L Meeks, B. Gangadharan, S. Meeks, 2012, Blood.

Antigenicity of putative phospholipid membrane-binding residues in factor VIII.

J. Healey, P. Lollar, J. Saint-Remy, 2001, Blood.

Analysis of the Human Factor VIII A2 Inhibitor Epitope by Alanine Scanning Mutagenesis*

J. Healey, P. Lollar, I. Lubin, 1997, The Journal of Biological Chemistry.

VIII molecules antibody plasmas using multiply-substituted hybrid human/porcine factor Reduction of the antigenicity of factor VIII toward complex inhibitory

J. Healey, P. Lollar, D. Scandella, 2013 .

Non‐classical anti‐factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model

S. Meeks, J. Healey, P. Lollar, 2008, Journal of thrombosis and haemostasis : JTH.